Cargando…

Impact of the Covid‐19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings

OBJECTIVES: This study aimed to determine the impact of the Covid‐19 pandemic on neuropsychiatric symptoms and antipsychotic use in people with dementia living in nursing homes. METHODS: This was a comparative analysis of baseline data from two large nursing home studies, one conducted during (COVID...

Descripción completa

Detalles Bibliográficos
Autores principales:	McDermid, Joanne, Ballard, Clive, Khan, Zunera, Aarsland, Dag, Fox, Chris, Fossey, Jane, Clare, Linda, Moniz‐Cook, Esme, Soto‐Martin, Maria, Sweetnam, Adrienne, Mills, Kathryn, Cummings, Jeffrey, Corbett, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286750/ https://www.ncbi.nlm.nih.gov/pubmed/36704984 http://dx.doi.org/10.1002/gps.5878

Ejemplares similares

Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes
por: Mueller, Christoph, et al.
Publicado: (2020)

Psychiatric and neuropsychiatric syndromes and COVID-19
por: Velayudhan, Latha, et al.
Publicado: (2020)

Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial
por: Ballard, Clive, et al.
Publicado: (2018)

Feasibility study of an optimised person-centred intervention to improve mental health and reduce antipsychotics amongst people with dementia in care homes: study protocol for a randomised controlled trial
por: Whitaker, Rhiannon, et al.
Publicado: (2013)

Improving Well-being and Health for People with Dementia (WHELD): study protocol for a randomised controlled trial
por: Whitaker, Rhiannon, et al.
Publicado: (2014)

Loneliness, physical activity, and mental health during COVID-19: a longitudinal analysis of depression and anxiety in adults over the age of 50 between 2015 and 2020
por: Creese, Byron, et al.
Publicado: (2020)

Cognitive stimulation therapy: training, maintenance and implementation in clinical trials
por: Khan, Zunera, et al.
Publicado: (2014)

Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011–2022 Update
por: Rogowska, Marianna, et al.
Publicado: (2022)

Mental health of people living with dementia in care homes during COVID-19 pandemic
por: Velayudhan, Latha, et al.
Publicado: (2020)

Levels of Loneliness and Mental Health in Older Adults across Ethnic Groups During the COVID-19 Pandemic in the UK
por: Khan, Zunera, et al.
Publicado: (2023)

The importance of co-pathologies on neuropsychiatric symptoms in dementia
por: Gibson, Lucy L., et al.
Publicado: (2022)

Genetic risk for Alzheimer's disease, cognition, and mild behavioral impairment in healthy older adults
por: Creese, Byron, et al.
Publicado: (2021)

Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease
por: Creese, Byron, et al.
Publicado: (2023)

Neuropsychological Impact of West Nile Virus Infection: An Extensive Neuropsychiatric Assessment of 49 Cases in Canada
por: Samaan, Zainab, et al.
Publicado: (2016)

Investigating the effects of impairment in non‐verbal communication on neuropsychiatric symptoms and quality of life of people living with dementia
por: Khan, Zunera, et al.
Publicado: (2021)

Antipsychotic prescribing in dementia
por: McLoughlin, James, et al.
Publicado: (2021)

Self-harm and Suicidality Experiences of Middle-Age and Older Adults With vs. Without High Autistic Traits
por: Stewart, Gavin R., et al.
Publicado: (2022)

Exploring the role of external experts in supporting staff to implement psychosocial interventions in care home settings: results from the process evaluation of a randomized controlled trial
por: Surr, Claire A., et al.
Publicado: (2019)

Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia
por: Lee, Philip E, et al.
Publicado: (2006)

Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial
por: Husebo, Bettina S, et al.
Publicado: (2011)

Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers
por: Gibson, Lucy L., et al.
Publicado: (2023)

International relevance of two measures of awareness of age-related change (AARC)
por: Sabatini, Serena, et al.
Publicado: (2020)

Differentiating traits and states identifies the importance of chronic neuropsychiatric symptoms for cognitive prognosis in mild dementia
por: Giil, Lasse M., et al.
Publicado: (2021)

Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022
por: Abdelnour, Carla, et al.
Publicado: (2023)

Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study
por: Stubendorff, Kajsa, et al.
Publicado: (2014)

Psychosis in Alzheimer’s Disease
por: Ballard, Clive, et al.
Publicado: (2020)

Memory clinics in context
por: Jolley, David, et al.
Publicado: (2009)

The memory clinic and psychosocial intervention: Translating past promise into current practices
por: Moniz-Cook, Esme, et al.
Publicado: (2023)

Antipsychotic and Psychotropic Prescribing in Assisted Living
por: Zimmerman, Sheryl, et al.
Publicado: (2020)

Antipsychotics in elderly people: to prescribe or to ban?
por: Zbidi, M., et al.
Publicado: (2023)

Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)
por: Erdal, Ane, et al.
Publicado: (2018)

FLAME: A computerized neuropsychological composite for trials in early dementia
por: Brooker, Helen, et al.
Publicado: (2020)

Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?
por: Bloniecki, Victor, et al.
Publicado: (2020)

What's new in critical illness and injury science? The costs of having a fall in Qatar!
por: McDermid, Robert C.
Publicado: (2013)

Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer’s Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil
por: Killick, Richard, et al.
Publicado: (2023)

Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics—a European study
por: Broekema, W. J., et al.
Publicado: (2007)

Antipsychotic polypharmacy prescribing and risk of hospital readmission
por: Kadra, Giouliana, et al.
Publicado: (2017)

Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM)
por: Erdal, Ane, et al.
Publicado: (2018)

Cost-Effectiveness of Dementia Care Mapping in Care-Home Settings: Evaluation of a Randomised Controlled Trial
por: Meads, David M., et al.
Publicado: (2019)

Off-label prescribing of antipsychotics: prescribing practices and clinical experiences of Finnish physicians
por: Rautio, N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_flaihvdbplsfseeg9ddn7ths8k